MedTrace Logo

Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds

NCT00971048 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2014-01-27

Study results available
· View outcomes & findings →

Summary

To compare HP828-101 to standard of care for the management of partial or full thickness wounds

Conditions

  • Diabetic Foot Ulcers
  • Pressure Ulcers

Interventions

DEVICE

HP828-101

Topical test article applied once daily

DEVICE

Hydrogel/Hydrocolloid

Hydrogel for DFU and Hydrocolloid for PU (3M Tegaderm Hydrogel for DFU; ConvaTec DuoDERM Hydroactive Gel for PU); Topical test articles applied once daily

Sponsors & Collaborators

  • Healthpoint

    lead INDUSTRY

Principal Investigators

  • Innes Cargill, PhD · Healthpoint, Ltd

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00971048 on ClinicalTrials.gov